Search Results

You are looking at 111 - 120 of 370 items for :

  • "therapeutics" x
  • Refine by Access: All x
Clear All
Full access

Being Closer to Normal

Margaret Tempero

, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR/ASCO Methods in Clinical Cancer

Full access

Point: Chemosensitivity Assays Have a Role in the Management of Recurrent Ovarian Cancer

Julian C. Schink and Larry J. Copeland

the use of assay-directed therapy is from studies of the ChemoFx assay (Precision Therapeutics, Pittsburgh, Pennsylvania). Gallion et al. 10 evaluated the value of this chemosensitivity assay test for predicting progression-free interval in 135 women

Full access

Giving Thanks

Margaret Tempero

JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer

Full access

Santa, Can You Hear Me?

Margaret Tempero

UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President

Full access

My Summer Vacation

Margaret Tempero

Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as

Full access

Kids, There’s an App for That!

pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR

Full access

Letter to Santa

Margaret Tempero

research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation

Full access

A New Beginning

Margaret Tempero

-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO

Full access

Changes on the Horizon

Margaret Tempero and JNCCN Staff

JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer

Full access

Being Sick Isn’t Easy

Margaret Tempero

, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR/ASCO Methods in Clinical Cancer